Skip to content

Author

Nikolaos Kotsopoulos

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Societal and fiscal gains from HPV vaccination in Poland - return on investment from extending access to HPV vaccination.

OBJECTIVE To evaluate the societal and fiscal impact of extending the current human papillomavirus (HPV) vaccination program in Poland (boys and girls aged 9-14 with average 20% vaccine coverage) by expanding age eligibility (9-17 years) and increasing vaccination coverage. METHODS A cost-benefit analysis was conduct...

Rafał Jaworski, Nikolaos Kotsopoulos, Marcin Czech et al. · 0 citations
Open access Aug 2026

Unlocking the value of RSV vaccination in Japan: a return on investment analysis using an integrated actuarial-macroeconomic model

Overall, adjuvanted RSVPreF3 vaccination among older adults in Japan represents good value for money from a societal perspective, where vaccine acquisition and administration costs are expected to be outweighed by substantial health, productivity, and broader economic benefits.

Eleftherios Zarkadoulas, A. Akimoto, Deven Chauhan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.